Thailand’s National Vaccine Institute (NVI), together with the Thailand vaccine and biological products quality assurance and quality control (QA/QC) network, organised a hybrid conference under the topic “Trend of Quality Control along Manufacturing Process” during 28-29 April 2022.
The Department of Medical Sciences has found that a combined formula between a full inactivated vaccine and an mRNA-based vaccine as a booster produces a high level of immunity against both the Delta and Omicron coronavirus variants.
The Department of Medical Sciences has found that administering an mRNA-based vaccine such as Pfizer or Moderna as a booster after initial doses of old-technology vaccines like Sinovac and/or AstraZeneca produces a high level of immunity against both the Delta and Omicron coronavirus variants.